The Image Computing, Analysis and Repository Facility, or ICAR (an expansion of the former Scientific Image Reconstruction and Analysis Facility or SIRAF) provides computing infrastructure, image analysis software, expert consultation, image-archiving and image analysis services to researchers across the University of Chicago Comprehensive Cancer Center (UCCCC). The Core's computing facilities include a cluster with nearly 300 CPU cores and 48 TB of data storage, used for high-intensity computation associated with image reconstruction, analysis and visualization. The intention of this Facility is to provide capability far above that available from an individual investigator?s workstation, while also allowing interactive respon,3e and quick turnaround, features lacking from larger scale facilities such as the Beagle high performance computer in the University's Computation Institute. The Core's computing facilities are heavily used by translational researchers in development of imaging techniques for cancer diagnosis, treatment and assessment. The image analysis mission of the ICAR Facility is to allow researchers, whose focus is not imaging per se, but cancer-related, to take maximum advantage of the available imaging modalities - supplying expertise in image analysis at whatever level is required - whether simple consultation and recommendation, shared development of new analysis software for use by researchers who wish to do their own processing, or turnkey end-to-end analysis and delivery of results for researchers who prefer to view imaging as a

Public Health Relevance

The importance of biomedical imaging continues to grow, presenting increasing demands for better and faster image post-processing to handle the flood of image data that can be produced from multimodality and serial imaging studies. Continuing development of these techniques by imaging scientists in collaboration with clinicians has been and continues to be a major thrust of the ICAR Facility. Preclinical imaging also continues to grow in importance, and the Facility provides a critical resource for cancer researchers who are not imaging specialists to maximize the scientific value of imaging in their research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-39
Application #
8744837
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
39
Fiscal Year
2014
Total Cost
$67,936
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Day, Kasey J; Casler, Jason C; Glick, Benjamin S (2018) Budding Yeast Has a Minimal Endomembrane System. Dev Cell 44:56-72.e4
Girard, Romuald; Zeineddine, Hussein A; Koskimäki, Janne et al. (2018) Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res 122:1716-1721
Pectasides, Eirini; Stachler, Matthew D; Derks, Sarah et al. (2018) Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov 8:37-48
Pu, Jinyue; Kentala, Kaitlin; Dickinson, Bryan C (2018) Multidimensional Control of Cas9 by Evolved RNA Polymerase-Based Biosensors. ACS Chem Biol 13:431-437
Liu, Hongtao; Zha, Yuanyuan; Choudhury, Noura et al. (2018) WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia. Exp Hematol Oncol 7:1
Nageeb, Shaheen; Vu, Milkie; Malik, Sana et al. (2018) Adapting a religious health fatalism measure for use in Muslim populations. PLoS One 13:e0206898
Ferreira, Caroline M; Williams, Jesse W; Tong, Jiankun et al. (2018) Allergen Exposure in Lymphopenic Fas-Deficient Mice Results in Persistent Eosinophilia Due to Defects in Resolution of Inflammation. Front Immunol 9:2395
Luke, Jason J; Lemons, Jeffrey M; Karrison, Theodore G et al. (2018) Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol 36:1611-1618
Wang, Amy Y; Weiner, Howard; Green, Margaret et al. (2018) A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. J Hematol Oncol 11:4
Sample, Ashley; He, Yu-Ying (2018) Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed 34:13-24

Showing the most recent 10 out of 668 publications